Skip to content

Vaasa Childhood Obesity Primary Prevention Study

Vaasa Childhood Obesity Primary Prevention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00970710
Acronym
VACOPP
Enrollment
185
Registered
2009-09-02
Start date
2009-01-01
Completion date
2017-01-31
Last updated
2017-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Obesity Pevention

Brief summary

This study aims to prevent childhood obesity with early life (pregnancy) intensified counselling. The recruited intervention group is pregnant mothers who are at risk to get gestational diabetes. Lifestyle intervention (nutritional and physical activity) begins during pregnancy in maternity clinics and continues in child wellfare clinics until the child is 5 years of age.

Interventions

BEHAVIORALVaasa Childhood Obesity Primary Prevention Study

Intensified counselling concerning healthy diet and suitable physical activity during pregnancy to mothers in the intervention group continuing in child health care clinic visits with the offspring until child's age of 5 year.

Sponsors

Foundation for Paediatric Research, Finland
CollaboratorOTHER
Vaasa Health care center
CollaboratorUNKNOWN
Seinajoki Central Hospital
CollaboratorOTHER
Tampere University Hospital
CollaboratorOTHER
Tampere University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Pragmatic controlled trial

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women who are at risk to get gestational diabetes.

Exclusion criteria

* Foreigner with language problems * Major psychosocial problems * Diabetes mellitus type I or II * Physical disability, * Major medical problems in pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Preventing childhood obesityOffspring age until six yearsDifference in offspring weight gain compared to control group

Secondary

MeasureTime frame
lower cholesterol valuesup to six years
lower HOMA-indexup to six years

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026